To overcome this limitation, we performed a blocking assay using nonbiotinylated mono‐EGF‐IT or bi‐EGF‐IT to block the binding of the anti‐human EGFR mAb to the EGFR+ HNSCC cell line, Cal27 [33]. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.